✓ Translated by DotMD AI Clinical Council Source: New England Journal of Medicine • Peer-Reviewed Journal (Clinical Trials)

Verify Primary Source: NIH PubMed PMID #NEJM-1332772225

Plain-English Research Story • 8th-Grade Reading Level

Can This Approach Help? Inside the Latest Research on Continuous Glucose Monitoring in Non–Insulin-Treated Type 2

New England Journal of Medicine, Volume 395, Issue 17 , Page 1717-1727, October 29, 2026.

Original Paper Title: “Continuous Glucose Monitoring in Non–Insulin-Treated Type 2 Diabetes” (New England Journal of Medicine, 2026-10-14)

Elena Rostova (AI Quant) Rigor Score

95 / 100

Sample Size (Participants)

Systematic Review

Evidence Classification

Peer-Reviewed Journal (Clinical Trials)

Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways

The Bottom-Line Finding: Indexed from New England Journal of Medicine (2026-10-14) by DotMD's 2-hour clinical surveillance pipeline.
Who Was Studied: Peer-Reviewed Journal (Clinical Trials) published in New England Journal of Medicine following multiple clinical patient groups.
Strength of the Evidence: Earned a 95/100 Study Rigor Score based on trial design, sample size, and peer-reviewed controls.
Smart Next Step: Share this plain-English summary with your doctor or pharmacist before starting, stopping, or changing any treatment.

The Full Story in Plain English

What the Study Found (In Plain English)

New England Journal of Medicine, Volume 395, Issue 17 , Page 1717-1727, October 29, 2026. Indexed from New England Journal of Medicine (2026-10-14) by DotMD's 2-hour clinical surveillance pipeline.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Published in New England Journal of Medicine (2026-10-14) • Study Design: Peer-Reviewed Journal (Clinical Trials) • Participants: Pooled Clinical Review • Biostatistical Rigor Score: 95/100. Primary Takeaway: Indexed from New England Journal of Medicine (2026-10-14) by DotMD's 2-hour clinical surveillance pipeline.

Study Limitations & Caveats Before You Act

While this peer-reviewed journal (clinical trials) scored 95/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.

Formal Peer-Reviewed Study Reference

“Continuous Glucose Monitoring in Non–Insulin-Treated Type 2 Diabetes”

Published in New England Journal of Medicine (2026-10-14) • PMID/ID: NEJM-1332772225

Read Formal Study

Related DotMD Clinical Hubs & Price Ledgers

Rx: insulin-aspart → Rx: insulin-aspart-szjj → Rx: insulin-lispro → Condition: diabetes →

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID NEJM-1332772225: Can This Approach Help? Inside the Latest Research on Continuous Glucose Monitoring in Non–Insulin-Treated Type 2

3 of 3 Free Questions Remaining